Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Phase II Study of Sunitinib Versus Dacarbazine in Metastatic Uveal Melanoma
2008-008794-55Phase 2Completed
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sunitinib in uveal melanoma (UM) and Malignant melanoma of other specified sites (MM) (2 arms), sponsored by The Clatterbridge Cancer Centre NHS Foundation Trust. Primary endpoint: Progression-free survival. Started Mar 2010; status: completed.
02
Drugs
sunitinib
03
Conditions
uveal melanoma (UM)Malignant melanoma of other specified sites (MM)
Beyond the preview
Go deeper on 2008-008794-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008794-55.